Literature DB >> 10639474

Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments.

F Velge-Roussel1, P Marcelo, A C Lepage, D Buzoni-Gatel, D T Bout.   

Abstract

Intranasal (i.n.) immunization with the SAG1 protein of Toxoplasma gondii plus cholera toxin (CT) provides protective immunity. The aim of this study was to analyze the cellular activation of several mucosal compartments after i.n. immunization. Cervical and mesenteric lymph node (CLN and MLN, respectively) lymphoid cell and intraepithelial lymphocyte (IEL) passive transfer experiments were performed with CBA/J mice immunized i.n. with SAG1 plus CT. CLN and MLN cells and IEL isolated 42 days after immunization conferred protective immunity on naive recipient mice challenged with strain 76K T. gondii, as assessed by the reduction in the number of brain cysts. There were proliferative specific responses in nose-associated lymphoid tissue and the CLN and MLN cells from mice immunized with SAG1 plus CT, but no cytokine was detectable. Thus, protective immunity is associated with a specific cellular response in the nasal and mesenteric compartments after i.n. immunization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639474      PMCID: PMC97233          DOI: 10.1128/IAI.68.2.969-972.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection.

Authors:  D Buzoni-Gatel; H Debbabi; M Moretto; I H Dimier-Poisson; A C Lepage; D T Bout; L H Kasper
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

Review 2.  Molecular and cellular basis of immune protection of mucosal surfaces.

Authors:  J P Kraehenbuhl; M R Neutra
Journal:  Physiol Rev       Date:  1992-10       Impact factor: 37.312

Review 3.  The mucosal immune system: from fundamental concepts to vaccine development.

Authors:  J R McGhee; J Mestecky; M T Dertzbaugh; J H Eldridge; M Hirasawa; H Kiyono
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

4.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

5.  Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens.

Authors:  T Chardès; I Bourguin; M N Mevelec; J F Dubremetz; D Bout
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

6.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody.

Authors:  L H Kasper; J H Crabb; E R Pfefferkorn
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

8.  Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.

Authors:  I Bourguin; T Chardès; D Bout
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

Authors:  T Chardès; F Velge-Roussel; P Mevelec; M N Mevelec; D Buzoni-Gatel; D Bout
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

10.  Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation.

Authors:  D Guy-Grand; N Cerf-Bensussan; B Malissen; M Malassis-Seris; C Briottet; P Vassalli
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  17 in total

1.  Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system.

Authors:  Christina D Steel; Suzanne M Hahto; Richard P Ciavarra
Journal:  Virology       Date:  2009-03-04       Impact factor: 3.616

2.  Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii.

Authors:  Hira Ram; J R Rao; A K Tewari; P S Banerjee; A K Sharma
Journal:  Parasitol Res       Date:  2013-04-10       Impact factor: 2.289

3.  Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzae.

Authors:  Linda E Winter; Stephen J Barenkamp
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

4.  Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.

Authors:  Lauren M Staska; Christopher J Davies; Wendy C Brown; Travis C McGuire; Carlos E Suarez; Joo Youn Park; Bruce A Mathison; Jeffrey R Abbott; Timothy V Baszler
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice.

Authors:  Valerie Letscher-Bru; Alexander W Pfaff; Ahmed Abou-Bacar; Denis Filisetti; Elisabeth Antoni; Odile Villard; Jean-Paul Klein; Ermanno Candolfi
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.

Authors:  C Bonenfant; I Dimier-Poisson; F Velge-Roussel; D Buzoni-Gatel; G Del Giudice; R Rappuoli; D Bout
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  A novel PAN/apple domain-containing protein from Toxoplasma gondii: characterization and receptor identification.

Authors:  Haiyan Gong; Kyousuke Kobayashi; Tatsuki Sugi; Hitoshi Takemae; Hitomi Kurokawa; Taisuke Horimoto; Hiroomi Akashi; Kentaro Kato
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

8.  Phenotype and function of nasal dendritic cells.

Authors:  H Lee; D Ruane; K Law; Y Ho; A Garg; A Rahman; D Esterházy; C Cheong; E Goljo; A G Sikora; D Mucida; B K Chen; S Govindraj; G Breton; S Mehandru
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

9.  Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis.

Authors:  Li-Tian Yin; Hai-Xia Hao; Hai-Long Wang; Jian-Hong Zhang; Xiao-Li Meng; Guo-Rong Yin
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

10.  Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.

Authors:  C Fromantin; B Jamot; J Cohen; L Piroth; P Pothier; E Kohli
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.